ArticleEClinicalMedicine2024

Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.

Li Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.